PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Esih, H.* ; Mezgec, K.* ; Billmeier, M.* ; Malenšek, Š.* ; Benčina, M.* ; Grilc, B.* ; Vidmar, S.* ; Gašperlin, M.* ; Bele, M.* ; Zidarn, M.* ; Zupanc, T.L.* ; Morgan, T.* ; Jordan, I.* ; Sandig, V.* ; Schrödel, S.* ; Thirion, C.* ; Protzer, U. ; Wagner, R.* ; Lainšček, D.* ; Jerala, R.*

Mucoadhesive film for oral delivery of vaccines for protection of the respiratory tract.

J. Control. Release 371, 179-192 (2024)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
The delivery of vaccines plays a pivotal role in influencing the strength and longevity of the immune response and controlling reactogenicity. Mucosal immunization, as compared to parenteral vaccination, could offer greater protection against respiratory infections while being less invasive. While oral vaccination has been presumed less effective and believed to target mainly the gastrointestinal tract, trans-buccal delivery using mucoadhesive films (MAF) may allow targeted delivery to the mucosa. Here we present an effective strategy for mucosal delivery of several vaccine platforms incorporated in MAF, including DNA plasmids, viral vectors, and lipid nanoparticles incorporating mRNA (mRNA/LNP). The mRNA/LNP vaccine formulation targeting SARS-CoV-2 as a proof of concept remained stable within MAF consisting of slowly releasing water-soluble polymers and an impermeable backing layer, facilitating enhanced penetration into the oral mucosa. This formulation elicited antibody and cellular responses comparable to the intramuscular injection, but also induced the production of mucosal IgAs, highlighting its efficacy, particularly for use as a booster vaccine and the potential advantage for protection against respiratory infections. The MAF vaccine preparation demonstrates significant advantages, such as efficient delivery, stability, and simple noninvasive administration with the potential to alleviate vaccine hesitancy.
Impact Factor
Scopus SNIP
Altmetric
10.500
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Mucoadhesive Film ; Mucosal Immunity ; Respiratory Infection ; Vaccine Delivery
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 0168-3659
e-ISSN 1873-4995
Zeitschrift Journal of Controlled Release
Quellenangaben Band: 371, Heft: , Seiten: 179-192 Artikelnummer: , Supplement: ,
Verlag Elsevier
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Virology (VIRO)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-003
G-502799-701
DOI 10.1016/j.jconrel.2024.05.041
Scopus ID 85194301751
PubMed ID 38795814
Erfassungsdatum 2024-06-17
[➜Korrektur melden]